IRF4 and chronic myelogenous leukemia, BCR-ABL1 positive: The expression ofthis gene is decreased in CML, AML, and chronicmyelomonocytic leukemia (CMMoL) patients, andincreased expression of IRF4 is associated with goodresponse to IFN-alpha therapy (51).